This webinar will bring together experts in preclinical trial design, R&D efficiency and regulatory affairs to offer advice on how companies can best engage the FDA early in the research process.

Topics include:

• Strategies for determining the best timeline for approaching the FDA with a new drug candidate
• A review of new technologies designed to speed up preclinical testing
• How fast is too fast? Ensuring the proper balance between streamlining preclinical research and gathering enough data to satisfy regulators